SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer
Shruthy Suresh1, Deniz Durakoglugil1, Xiaorong Zhou1,2
1Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, United States of America.
Abstract:
Hepatocellular carcinoma (HCC) is the fifth most common solid tumor in the world and the third leading cause of cancer-associated deaths. A Sleeping Beauty-mediated transposon mutagenesis screen previously identified mutations that cooperate with MYC to accelerate liver tumorigenesis. This revealed a tumor suppressor role for Steroid Receptor Coactivator 2/Nuclear Receptor Coactivator 2 (Src-2/Ncoa2) in liver cancer. In contrast, SRC-2 promotes survival and metastasis in prostate cancer cells, suggesting a tissue-specific and context-dependent role for SRC-2 in tumorigenesis. To determine if genetic loss of SRC-2 is sufficient to accelerate MYC-mediated liver tumorigenesis, we bred Src-2-/- mice with a MYC-induced liver tumor model and observed a significant increase in liver tumor burden. RNA sequencing of liver tumors and in vivo chromatin immunoprecipitation assays revealed a set of direct target genes that are bound by SRC-2 and exhibit downregulated expression in Src-2-/- liver tumors. We demonstrate that activation of SHP (Small Heterodimer Partner), DKK4 (Dickkopf-4), and CADM4 (Cell Adhesion Molecule 4) by SRC-2 suppresses tumorigenesis in vitro and in vivo. These studies suggest that SRC-2 may exhibit oncogenic or tumor suppressor activity depending on the target genes and nuclear receptors that are expressed in distinct tissues and illuminate the mechanisms of tumor suppression by SRC-2 in liver.
Insights
Steroid Receptor Coactivator 2 (SRC-2) acts as a tumor suppressor in liver cancer, accelerating MYC-driven tumors when lost. Its activation of SHP, DKK4, and CADM4 inhibits liver tumorigenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a major global cancer with high mortality.
- Previous studies identified MYC cooperation in liver tumorigenesis, revealing a tumor suppressor role for Steroid Receptor Coactivator 2 (SRC-2/Ncoa2) in liver cancer.
- SRC-2 exhibits context-dependent roles, promoting cancer progression in prostate cancer.
Purpose of the Study:
- To investigate if genetic loss of SRC-2 accelerates MYC-mediated liver tumorigenesis.
- To identify direct SRC-2 target genes involved in liver tumor suppression.
- To elucidate the mechanisms by which SRC-2 suppresses liver cancer.
Main Methods:
- Utilized a Sleeping Beauty transposon mutagenesis screen and MYC-induced liver tumor models in mice.
- Generated and analyzed Src-2 knockout (Src-2-/-) mice.
- Performed RNA sequencing and in vivo chromatin immunoprecipitation assays.
Main Results:
- Genetic loss of SRC-2 significantly increased liver tumor burden in MYC-driven models.
- Identified direct SRC-2 target genes (SHP, DKK4, CADM4) downregulated in Src-2-/- tumors.
- Demonstrated that SRC-2 activation of SHP, DKK4, and CADM4 suppresses liver tumorigenesis in vitro and in vivo.
Conclusions:
- SRC-2 functions as a tumor suppressor in liver cancer, contrasting its role in other cancers.
- SRC-2-mediated suppression of SHP, DKK4, and CADM4 is a key mechanism in preventing liver tumorigenesis.
- SRC-2's oncogenic or tumor suppressor activity is tissue- and context-dependent.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mechanisms of Retrovirus-induced Cancers
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...


